Neuroscience-based nomenclature as a teaching tool, introduction and pilot study

被引:1
|
作者
Zemach, Sasson [1 ]
Levy, Daniel Minkin [1 ]
Zohar, Joseph [2 ,3 ]
机构
[1] Jerusalem Mental Hlth Ctr, Womens Inpatient Unit, Tel Hashomer, Israel
[2] Sheba Med Ctr, Dept Psychiat, Tel Hashomer, Israel
[3] Tel Aviv Univ, Sackler Sch Med, IL-5265602 Tel Aviv, Israel
关键词
nomenclature; psychiatry; psychopharmacology; student views; NBN;
D O I
10.1097/YIC.0000000000000470
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neuroscience-based nomenclature (NbN) is a pharmacologically-driven nomenclature aiming to replace the current disease-based nomenclature of psychotropics, focusing on pharmacology and mode-of-action to encourage scientifically-minded prescribing. NbN might also be used as a teaching tool as it presents the depth and richness of the neuroscience of psychotropics. This study examines the effect of using NbN in student curriculum. Fifty-six medical students during clerkship in psychiatry, divided into a control group (n = 20), taught standard psychopharmacology, and an intervention group (n = 36) introduced with NbN. Both groups filled out identical questionnaires at the beginning and end of the clerkship, including questions of knowledge on psychopharmacology, views on current terminology and interest in psychiatric residency. Comparing the average change in scorings (delta post-pre) for each item in intervention vs. control questionnaires, the intervention group showed a significantly larger positive delta in 6 out of 10 items than the control group. Mean scores did not differ significantly between the two groups in the pre-questionnaires, while significantly higher scores were shown for the intervention group in within- and between-group comparisons. Introduction of NbN was associated with a better educational experience, a deeper understanding of psychotropics and increased interest in psychiatric residency.
引用
收藏
页码:329 / 335
页数:7
相关论文
共 50 条
  • [1] Neuroscience-based nomenclature (NbN)
    Worley, Luke
    [J]. LANCET PSYCHIATRY, 2017, 4 (04): : 272 - 273
  • [2] A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature
    Zohar, Joseph
    Stahl, Stephen
    Moller, Hans-Jurgen
    Blier, Pierre
    Kupfer, David
    Yamawaki, Shigeto
    Uchida, Hiroyuki
    Spedding, Michael
    Goodwin, Guy M.
    Nutt, David
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (12) : 2318 - 2325
  • [3] The importance of the neuroscience-based nomenclature
    Zohar, Joseph
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 7 - 7
  • [4] Neuroscience-based nomenclature in Ukraine
    Zubatiuk, O.
    Nosova, E.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S663 - S663
  • [5] Neuroscience-based nomenclature and medicolegal significance
    Ramadas, Smitha
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2016, 58 (03) : 346 - 346
  • [6] Neuroscience-Based Nomenclature for Psychotropic Medication
    Hutson, Elizabeth
    Ellington, Erin
    Hardy, Lyons
    [J]. JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2023, 61 (07) : 9 - 13
  • [7] Neuroscience-based Nomenclature (NbN) for Clinical Psychopharmacology and Neuroscience
    Uchida, Hiroyuki
    Yamawaki, Shigeto
    Bahk, Won-Myong
    Jon, Duk-In
    [J]. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2016, 14 (02) : 115 - 116
  • [8] Neuroscience-based nomenclature of psychotropics: Progress report
    Zohar, Joseph
    Levy, Daniel Minkin
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2022, 57 : 36 - 38
  • [9] Neuroscience-based Nomenclature (NbN): A call for action
    Zohar, Joseph
    Kasper, Siegfried
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2016, 17 (05): : 318 - 320
  • [10] Neuroscience-based Nomenclature (NbN) for Journal of Psychopharmacology
    Nutt, David J.
    Blier, Pierre
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (05) : 413 - 415